Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

Many Doctors Don’t Recommend Taking Baby Aspirin To Prevent Heart Attacks, Despite Guidelines
2014-08-08 03:37:55

University of Rochester Medical Center A majority of middle-aged men and women eligible to take aspirin to prevent heart attack and stroke do not recall their doctors ever telling them to do so, according to a University of Rochester study of a national sample of more than 3,000 patients. Published online by the Journal of General Internal Medicine, the finding illustrates a common disconnect between public health guidelines and what occurs in clinical practice. The UR study is...

2014-07-25 23:01:34

On July 21, the FDA informed that one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 25, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Ibuprofen and Oxcarbazepine...

2014-07-25 16:23:01

NEWARK, Calif., July 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2014 financial results after the market closes on Wednesday, August 6, 2014. The Company will host a conference call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on...

2014-07-17 16:26:16

Opinion Expected "In Short Order" NEWARK, Calif., July 17, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that on July 17, 2014, Judge Joel A. Pisano of the United States District Court for the District of New Jersey entered an order preliminarily enjoining Actavis Elizabeth LLC and Actavis Inc. from marketing a generic version of Gralise® (gabapentin) prior to the Court's issuance of an opinion in the matter. The order indicates the Court expects to issue an...

2014-07-16 08:27:57

NEWARK, Calif., July 16, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer and Senior Vice President. Dr. Rao has extensive experience and background in pain and central nervous system diseases. He was the Founder and Chief Executive Officer of Kyalin Biosciences, a privately held biotechnology company developing a potential breakthrough therapy for autism, from its formation in 2011 through to its...

2014-07-08 08:31:53

DUBLIN, July 8, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil(®) Congestion Relief Tablets, 200 mg/10 mg. Perrigo expects to begin shipments of the product prior to the upcoming cough/cold/flu season....

2014-07-01 08:31:24

· quellin(TM) (carprofen) soft chewable tablets help veterinarians alleviate the pain associated with canine osteoarthritis SHAWNEE, Kan., July 1, 2014 /PRNewswire/ -- Bayer HealthCare LLC Animal Health is pleased to announce the launch of quellin(TM) (carprofen) soft chewable tablets to help alleviate the pain associated with canine osteoarthritis, one of the most common causes of chronic pain in dogs--affecting 20 percent of dogs older than one year of age.(1) quellin(TM), the...

2014-06-25 08:30:55

GREENWOOD VILLAGE, Colo., June 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina(TM)). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%,...

2014-06-19 12:24:02

DUBLIN, June 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/twpmjd/global_and) has announced the addition of the "Global and Chinese Methyl Salicylate Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese Methyl Salicylate Industry Report 2014 is a professional and in-depth study on the current state of the global Methyl Salicylate industry with a focus on the Chinese situation....

2014-06-18 08:28:42

NEWARK, Calif., June 18, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2014 Healthcare Conference in New York City. The presentation at the JMP conference is scheduled for 11:30 am ET (8:30 am PT) on Tuesday June 24, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related